Kebriaeezadeh A - Search Results

1

Trends analysis and future study of the pharmaceutical industry field: a scoping review.

Bashirynejad M, Soleymani F, Nikfar S, Kebriaeezadeh A, Majdzadeh R, Fatemi B, Zackery A, Zare N. Bashirynejad M, et al. Among authors: kebriaeezadeh a. Daru. 2024 Dec 17;33(1):6. doi: 10.1007/s40199-024-00550-x. Daru. 2024. PMID: 39688735 Review.

2

Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?

Keshavarz K, Kebriaeezadeh A, Meshkini AH, Nikfar S, Mirian I, Khoonsari H. Keshavarz K, et al. Among authors: kebriaeezadeh a. Daru. 2012 Oct 22;20(1):62. doi: 10.1186/2008-2231-20-62. Daru. 2012. PMID: 23351226 Free PMC article.

3

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study.

Hashemi Meshkini A, Kebriaeezadeh A, Dinarvand R, Nikfar S, Habibzadeh M, Vazirian I. Hashemi Meshkini A, et al. Among authors: kebriaeezadeh a. Daru. 2012 Aug 30;20(1):19. doi: 10.1186/2008-2231-20-19. Daru. 2012. PMID: 23351841 Free PMC article.

4

Trend analysis of the pharmaceutical market in Iran; 1997-2010; policy implications for developing countries.

Kebriaeezadeh A, Koopaei NN, Abdollahiasl A, Nikfar S, Mohamadi N. Kebriaeezadeh A, et al. Daru. 2013 Jun 28;21(1):52. doi: 10.1186/2008-2231-21-52. Daru. 2013. PMID: 23805853 Free PMC article.

5

Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions.

Nassiri-Koopaei N, Majdzadeh R, Kebriaeezadeh A, Rashidian A, Yazdi MT, Nedjat S, Nikfar S. Nassiri-Koopaei N, et al. Among authors: kebriaeezadeh a. Daru. 2014 Feb 24;22(1):29. doi: 10.1186/2008-2231-22-29. Daru. 2014. PMID: 24568555 Free PMC article.

6

Consistent defined threshold and equity in health.

Nikfar S, Babar ZU, Dinarvand R, Kebriaeezadeh A, Abdollahi M. Nikfar S, et al. Among authors: kebriaeezadeh a. Daru. 2015 Feb 10;23(1):12. doi: 10.1186/s40199-015-0097-6. Daru. 2015. PMID: 25890072 Free PMC article. No abstract available.

7

Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.

Teimouri F, Kebriaeezadeh A, Zahraei SM, Gheiratian M, Nikfar S. Teimouri F, et al. Among authors: kebriaeezadeh a. Daru. 2017 Jan 14;25(1):1. doi: 10.1186/s40199-017-0166-0. Daru. 2017. PMID: 28088246 Free PMC article.

8

Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children.

Gharibnaseri Z, Kebriaeezadeh A, Nikfar S, Zamani G, Abdollahiasl A. Gharibnaseri Z, et al. Among authors: kebriaeezadeh a. Daru. 2012 Aug 30;20(1):17. doi: 10.1186/2008-2231-20-17. Daru. 2012. PMID: 23351726 Free PMC article.

9

Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments.

Nikfar S, Kebriaeezadeh A, Dinarvand R, Abdollahi M, Sahraian MA, Henry D, Akbari Sari A. Nikfar S, et al. Among authors: kebriaeezadeh a. Daru. 2013 Jun 22;21(1):50. doi: 10.1186/2008-2231-21-50. Daru. 2013. PMID: 23800250 Free PMC article.

10

A system dynamics model for national drug policy.

Abdollahiasl A, Kebriaeezadeh A, Dinarvand R, Abdollahi M, Cheraghali AM, Jaberidoost M, Nikfar S. Abdollahiasl A, et al. Among authors: kebriaeezadeh a. Daru. 2014 Apr 1;22(1):34. doi: 10.1186/2008-2231-22-34. Daru. 2014. PMID: 24690531 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters